Výsledky vyhledávání - Hongbing Huang
- Zobrazuji výsledky 1 - 10 z 10
-
1
-
2
Unconfined compressive strength prediction of rock materials based on machine learning Autor Lihong Niu, Qiang Cui, Jiangyun Luo, Hongbing Huang, Jing Zhang
Vydáno 2024-06-01
Článek -
3
-
4
-
5
-
6
Landscape of clinical drug development of ADCs used for the pharmacotherapy of cancers: an overview of clinical trial registry data from 2002 to 2022 Autor Wenjing Zhou, Zhiyuan Xu, Shu Liu, Xiaohuan Lou, Pengcheng Liu, Huali Xie, Shuiyan Zhang, Xi Liu, Baoshan Zhuo, Hongbing Huang
Vydáno 2024-07-01
Článek -
7
Retraction Note: N6-methyladenosine induced mir-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1 Autor Hongsheng Wang, Qianqian Deng, Ziyan Lv, Yuyi Ling, Xue Hou, Zhuojia Chen, Xiaoxiao Dinglin, Shuxiang Ma, Delan Li, Yingmin Wu, Yanxi Peng, Hongbing Huang, Likun Chen
Vydáno 2023-08-01
Článek -
8
RETRACTED ARTICLE: N6-methyladenosine induced miR-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1 Autor Hongsheng Wang, Qianqian Deng, Ziyan Lv, Yuyi Ling, Xue Hou, Zhuojia Chen, Xiaoxiao Dinglin, Shuxiang Ma, Delan Li, Yingmin Wu, Yanxi Peng, Hongbing Huang, Likun Chen
Vydáno 2019-12-01
Článek -
9
Rituximab exposure‐response in triweekly R‐CHOP treatment in DLBCL: A loading dose is recommended to improve clinical outcomes Autor Shu Liu, Zhao Wang, Rongxin Chen, He Huang, Xueding Wang, Chen Peng, Yanping Guan, Xiaojie Fang, Shaoxing Guan, Hongbing Huang, Tao Liu, Tongyu Lin, Min Huang
Vydáno 2022-03-01
Článek -
10
A Cost-Effectiveness Analysis: First-Line Avelumab Plus Axitinib Versus Sunitinib for Advanced Renal-Cell Carcinoma Autor Peiyao Lu, Weiting Liang, Jiahao Li, Yanming Hong, Zhuojia Chen, Tao Liu, Pei Dong, Hongbing Huang, Tiantian Zhang, Tiantian Zhang, Jie Jiang, Jie Jiang, Jie Jiang
Vydáno 2020-05-01
Článek